• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国中重度银屑病患者皮肤病生活质量指数与EQ-5D健康效用指数评分的映射关系

Mapping Dermatology Life Quality Index with EQ-5D health utility index score in Chinese patients with moderate to severe psoriasis.

作者信息

Jian Lu, Wang Xingzhi, Hu Kun, Duan Yongfang, Zhang Mi, Li Wei, Wang Pei, Tan Liang, Chen Wendong, Chen Tingyin, Li Juan, Kuang Yehong

机构信息

Xiangya Hospital of Central South University, Changsha, China.

Bristol-Myers Squibb, Shanghai, China.

出版信息

J Comp Eff Res. 2025 Sep;14(9):e250039. doi: 10.57264/cer-2025-0039. Epub 2025 Jul 18.

DOI:10.57264/cer-2025-0039
PMID:40679359
Abstract

To establish correlation between Dermatology Life Quality Index (DLQI) and EuroQol 5-Dimension questionnaire (EQ-5D) utility score in Chinese moderate-to severe psoriasis patients and develop mapping models for health utility prediction. A total of 287 patients with moderate to severe psoriasis and at least one clinical visit with assessments for both DLQI and EQ-5D in a Chinese tertiary hospital were included. These patients were randomly split into a training set (n = 231) and a testing set (n = 56). Correlation analyses were performed to assess the relationship between DLQI (total score and item score) and EQ-5D utility index score. Twelve predictive models were developed using three statistical model approaches (ordinary least squares model, Tobit model and generalized linear model), incorporating various combinations of DLQI scores and patient characteristics (age, sex, education and comorbidities). Models were evaluated using root mean square error and mean absolute error (MAE). A strong and significant correlation was found between DLQI total score and EQ-5D utility index score (r = -0.645, p < 0.001). The best-performing model, (ordinary least squares model using DLQI total score, had the lowest root mean square error (0.122) and MAE (0.076). Validation of this model in the testing set yielded a predicted utility score with an MAE of 0.072, and an MAE-to-utility ratio of 0.084, below the validation threshold of 0.1. DLQI scores can reliably predict health utility values, offering a useful tool for clinical decision-making and health economic evaluations. The model shows strong predictive accuracy and has potential applications in the management of msPsO in China.

摘要

在中国中重度银屑病患者中建立皮肤病生活质量指数(DLQI)与欧洲五维健康量表(EQ-5D)效用得分之间的相关性,并开发用于健康效用预测的映射模型。纳入了一家中国三级医院的287例中重度银屑病患者,这些患者至少有一次临床就诊且接受了DLQI和EQ-5D评估。将这些患者随机分为训练集(n = 231)和测试集(n = 56)。进行相关性分析以评估DLQI(总分和项目得分)与EQ-5D效用指数得分之间的关系。使用三种统计模型方法(普通最小二乘法模型、 Tobit模型和广义线性模型)开发了12个预测模型,纳入了DLQI得分和患者特征(年龄、性别、教育程度和合并症)的各种组合。使用均方根误差和平均绝对误差(MAE)对模型进行评估。发现DLQI总分与EQ-5D效用指数得分之间存在强且显著的相关性(r = -0.645,p < 0.001)。表现最佳的模型(使用DLQI总分的普通最小二乘法模型)具有最低的均方根误差(0.122)和MAE(0.076)。在测试集中对该模型进行验证,得出预测效用得分的MAE为0.072,MAE与效用比为0.084,低于验证阈值0.1。DLQI得分可以可靠地预测健康效用值,为临床决策和健康经济评估提供了有用的工具。该模型显示出强大的预测准确性,在中国中重度斑块状银屑病(msPsO)的管理中具有潜在应用价值。

相似文献

1
Mapping Dermatology Life Quality Index with EQ-5D health utility index score in Chinese patients with moderate to severe psoriasis.中国中重度银屑病患者皮肤病生活质量指数与EQ-5D健康效用指数评分的映射关系
J Comp Eff Res. 2025 Sep;14(9):e250039. doi: 10.57264/cer-2025-0039. Epub 2025 Jul 18.
2
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.使用通用和特定疾病健康相关生活质量测量指标进行 NICE 决策制定:系统评价、统计建模和调查。
Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090.
3
Mapping KDQOL-36 Onto EQ-5D-5L and SF-6Dv2 in Patients Undergoing Dialysis in China.中国血液透析患者中KDQOL-36与EQ-5D-5L及SF-6Dv2的映射研究
Value Health Reg Issues. 2025 Mar 8;48:101103. doi: 10.1016/j.vhri.2025.101103.
4
Health-related quality of life of adults with generalized pustular psoriasis in Malaysia: a cross-sectional study.马来西亚泛发性脓疱型银屑病成年人的健康相关生活质量:一项横断面研究。
Orphanet J Rare Dis. 2025 Aug 27;20(1):460. doi: 10.1186/s13023-025-03820-2.
5
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
6
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.从皮肤病生活质量指数生成 EQ-5D-3L 效用评分:一项针对银屑病患者的映射研究。
Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.
7
Health-related quality of life and correlation with clinical severity in patients with acne: a cross-sectional study at a single centre in China.痤疮患者的健康相关生活质量及其与临床严重程度的相关性:中国某单中心横断面研究
BMJ Open. 2025 Sep 2;15(9):e091036. doi: 10.1136/bmjopen-2024-091036.
8
Aphasia-specific or generic outcomes? a comparison of two health-related quality of life instruments for economic evaluations of aphasia treatments.失语症特异性结果还是一般性结果?两种用于失语症治疗经济评估的健康相关生活质量工具的比较。
Qual Life Res. 2025 Jul 26. doi: 10.1007/s11136-025-04040-8.
9
Efficacy and safety of tildrakizumab in patients with early- vs. late-onset psoriasis.替拉珠单抗治疗早发型与晚发型银屑病患者的疗效和安全性
Br J Dermatol. 2025 Aug 18;193(3):442-450. doi: 10.1093/bjd/ljaf171.
10
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA).用依那西普生物类似药 GP2015 治疗的类风湿关节炎、银屑病或银屑病关节炎患者的患者报告结局指标:两项 III 期研究(EGALITY 和 EQUIRA)的结果
Drugs R D. 2025 Apr 25. doi: 10.1007/s40268-025-00507-8.

本文引用的文献

1
Use of health technology assessment in drug reimbursement decisions in China.中国药品报销决策中的卫生技术评估使用。
BMJ. 2023 Jun 15;381:e068915. doi: 10.1136/bmj-2021-068915.
2
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?中国基于卫生技术评估的定价谈判:更有效的靶向抗癌药物是否意味着更高的谈判价格?
Health Res Policy Syst. 2022 Jan 3;20(1):3. doi: 10.1186/s12961-021-00810-1.
3
Psoriasis: a brief overview.银屑病:简要概述。
Clin Med (Lond). 2021 May;21(3):170-173. doi: 10.7861/clinmed.2021-0257.
4
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.银屑病的病理生理学、临床表现和治疗:综述。
JAMA. 2020 May 19;323(19):1945-1960. doi: 10.1001/jama.2020.4006.
5
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies.生物疗法治疗前后银屑病和银屑病关节炎患者的药物利用及医疗资源消耗分析
Biologics. 2018 Nov 12;12:151-158. doi: 10.2147/BTT.S168691. eCollection 2018.
6
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.从皮肤病生活质量指数生成 EQ-5D-3L 效用评分:一项针对银屑病患者的映射研究。
Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.
7
Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.使用有序逻辑回归将皮肤病生活质量指数(DLQI)得分映射为欧洲五维健康量表(EQ-5D)效用值。
Qual Life Res. 2017 Nov;26(11):3025-3034. doi: 10.1007/s11136-017-1607-4. Epub 2017 Jun 10.
8
Estimating an EQ-5D-5L Value Set for China.估算中国的EQ-5D-5L价值集。
Value Health. 2017 Apr;20(4):662-669. doi: 10.1016/j.jval.2016.11.016. Epub 2017 Feb 9.
9
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.探讨 EQ-5D、DLQI 和 PASI 之间的关系,并对 EQ-5D 效用进行映射:来自匈牙利的银屑病横断面研究。
Eur J Health Econ. 2014 May;15 Suppl 1:S111-9. doi: 10.1007/s10198-014-0600-x. Epub 2014 May 16.
10
The burden of moderate to severe psoriasis: an overview.中重度银屑病的负担:概述。
Pharmacoeconomics. 2012 Nov 1;30(11):1005-13. doi: 10.2165/11591580-000000000-00000.